[
  {
    "ts": "2024-12-05T16:30:48+00:00",
    "headline": "Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?",
    "summary": "Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finance.yahoo.com/news/globus-medical-gmed-2-1-163048736.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3ce37f3d-c370-337a-9c6b-5edd1b5d9353",
      "content": {
        "id": "3ce37f3d-c370-337a-9c6b-5edd1b5d9353",
        "contentType": "STORY",
        "title": "Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?",
        "description": "",
        "summary": "Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "pubDate": "2024-12-05T16:30:48Z",
        "displayTime": "2024-12-05T16:30:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2",
          "originalWidth": 900,
          "originalHeight": 625,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3cJ1IMl6d4bpPpYAD.IsQw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2.cf.webp",
              "width": 900,
              "height": 625,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PlkanZFCHurVHg.4Kx4ifw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/globus-medical-gmed-2-1-163048736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/globus-medical-gmed-2-1-163048736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMED"
            },
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2024-12-05T12:17:23+00:00",
    "headline": "Edwards expects new TAVR approval in mid-2025 to boost sales",
    "summary": "U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the growth catalysts Edwards outlined in an investor day presentation.",
    "url": "https://www.medtechdive.com/news/Edwards-investor-day-expects-2025-expanded-TAVR-indication/734747/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "b7511ba8-6494-39f2-be7e-c18cfc234bd1",
      "content": {
        "id": "b7511ba8-6494-39f2-be7e-c18cfc234bd1",
        "contentType": "STORY",
        "title": "Edwards expects new TAVR approval in mid-2025 to boost sales",
        "description": "",
        "summary": "U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the growth catalysts Edwards outlined in an investor day presentation.",
        "pubDate": "2024-12-05T12:17:23Z",
        "displayTime": "2024-12-05T12:17:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/a1369f1b68f2e9a9abc61dddae2be944",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Edwards Lifesciences' Irvine, California, campus.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D._VQ_2vNHK.y9UZ3YbbcA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/a1369f1b68f2e9a9abc61dddae2be944.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NGqdOhjfQmrXXCQbXISAQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/a1369f1b68f2e9a9abc61dddae2be944.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/Edwards-investor-day-expects-2025-expanded-TAVR-indication/734747/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-expects-tavr-approval-mid-121723545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]